Merquity Partners is led by a practicing surgeon and a finance & strategy advisor — bringing clients a rare combination of frontline clinical experience and institutional deal-making discipline.
A surgeon who trained at McKinsey. A dealmaker who has closed transactions for private equity. When they work the same engagement, clients get clinical judgment and financial firepower that usually require two separate firms — without the gap in between.
Double Board-Certified, General Surgery & Surgical Critical Care · Fellow, American College of Surgeons · Fellow, International College of Surgeons
Dr. Mallah is a double board-certified surgeon with over ten years of active clinical practice and more than 4,000 surgical cases performed across academic medical centers, low-resource settings, and conflict zones on five continents. His clinical range spans trauma surgery, surgical critical care, and general surgery, including recent service with a United Nations/World Health Organization–coordinated surgical team.
Before returning to full-time practice, Dr. Mallah spent three years as a management consultant with McKinsey & Company, advising C-suite healthcare executives, government health ministers, and large institutional health systems on strategy, operations, and market entry. He is also the inventor of a patent-pending medical device, giving him direct, firsthand experience with the regulatory and commercialization path facing medical technology innovators. He currently holds active medical licensure in North Carolina, South Carolina, and Virginia.
MBA, Simon Business School, University of Rochester · LLM, International Business Law, University of Dundee
Masih leads Merquity's financial, valuation, and transaction work. He currently serves as Growth Strategy & Market Insights Lead at Gen Digital, where he has directed commercial and financial due diligence on more than thirty potential M&A and growth partnerships and built the valuation and synergy models supporting executive go/no-go decisions.
His background spans private equity, strategy consulting, and corporate development — including an Investment Associate role at InFrontier Ltd. evaluating cross-border acquisitions across healthcare, energy, and technology, a corporate strategy role with Azizi Development structuring acquisitions and partnerships, and deal evaluation work with Cognizant across a $50M M&A transaction pipeline. He holds an MBA from the Simon Business School (Strategy & Finance) and an LLM in International Business Law from the University of Dundee, where he was a Chevening Scholar.
Every engagement draws on both founders — no hand-offs, no re-explaining your business to a new team.
Book a Free 30-Minute Call →